Retrospective evaluation of adverse events of neoadjuvant or induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal squamous cell carcinoma

By Sugawara Mitsuhiro  

Esophagus, Vol. 10, Iss. 2, 2013-06 ,pp. : 65-69

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy-induced toxicities and treatment efficacy in advanced esophageal cancer treated with neoadjuvant chemotherapy followed by surgery

By Motoori Masaaki  

Esophagus, Vol. 8, Iss. 2, 2011-06 ,pp. : 81-87

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases

By Yang Tsai-Shen   Chang Hsien-Khun   Chen Jen-Shi   Lin Yung-Chang   Liau Chi-Ting   Chang Wen-Cheng  

Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 362-369

Springer Publishing Company

Access to resources Recommend Favorite

Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-α for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis

By Eun Jong Ryul   Lee Heon Ju   Moon Hee Jung   Kim Tae Nyeun   Kim Jae Woon   Chang Jay Chun  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 12, 2009-12 ,pp. : 1477-1486

Informa Healthcare

Access to resources Recommend Favorite

Induction Chemotherapy with Docetaxel/Cisplatin/5-Fluorouracil for Patients with Node-Positive Esophageal Cancer

By  

Digestion, Vol. 83, Iss. 3, 2011-01 ,pp. : 146-152

Karger

Access to resources Recommend Favorite